Multi-Antigen Protein Vaccine Confers Protection in a Murine Model Against Intranasal Haemophilus influenzae Challenge
Vaccines · 17.04.2026 · 14 (4) · 357
DOI: 10.3390/vaccines14040357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 17.04.2026. Verfasst von Nouria Belkacem und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institut Pasteur, Université Paris Cité, Invasive Bacterial Infections Unit and National Reference Centre for Meningococci and Haemophilus Influenzae…. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Institut Pasteur grant ANR AB 2022 DARRI INNOV-204-24 TAHA, section analytique S-CR23002-08A., Institut Pasteur.
Abstract (Originalsprache)
Background
Non-typeable Haemophilus influenzae (NTHi) is a major cause of acute respiratory tract infections and chronic airway disease, despite its clinical importance, no licensed vaccine is available, largely due to the extensive genetic and antigenic diversity among circulating isolates. We previously identified conserved outer membrane proteins capable of inducing systemic protection against NTHi.
Methods
In this study, we evaluated whether a multi-antigen protein vaccine composed of conserved NTHi antigens (P5 and P26) could protect against pulmonary infection. Transgenic mice expressing human transferrin and factor H were immunized via the intraperitoneal or intranasal route and challenged intranasally with a clinical NTHi isolate. Bacterial clearance, antigen-specific mucosal and systemic antibody responses, and recruitment of innate immune cells to the airways were assessed.
Results
Both immunization routes significantly reduced bacterial loads compared with controls. Vaccination induced robust mucosal and systemic IgG and IgA responses and enhanced early recruitment of macrophages, monocytes, dendritic cells, and neutrophils to the airways. Intranasal immunization elicited strong mucosal antibody responses and was associated with improved local bacterial clearance.
Conclusions
These findings demonstrate that multi-antigen vaccines targeting conserved NTHi proteins can elicit effective mucosal and systemic immunity and represent promising candidates for the prevention against NTHi respiratory infections.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institut Pasteur, Université Paris Cité, Invasive Bacterial Infections Unit and National Reference Centre for Meningococci and Haemophilus Influenzae, CEDEX 15, 75724 Paris, France.
ORCID-Profile: Nouria Belkacem, Ala-Eddine Deghmane, Muhamed-Kheir Taha
Förderung
- the Institut Pasteur grant ANR AB 2022 DARRI INNOV-204-24 TAHA, section analytique S-CR23002-08A.
- Institut Pasteur
Zitieren
APA
Belkacem, N., Deghmane, A. E., & Taha, M. K. (2026). Multi-Antigen Protein Vaccine Confers Protection in a Murine Model Against Intranasal Haemophilus influenzae Challenge. Vaccines, 14(4), 357. https://doi.org/10.3390/vaccines14040357
Vancouver
Belkacem N, Deghmane AE, Taha MK. Multi-Antigen Protein Vaccine Confers Protection in a Murine Model Against Intranasal Haemophilus influenzae Challenge. Vaccines. 2026;14(4):357. doi:10.3390/vaccines14040357
BibTeX
@article{Belkacem2026,
author = {Belkacem, Nouria and Deghmane, Ala-Eddine and Taha, Muhamed-Kheir},
title = {Multi-Antigen Protein Vaccine Confers Protection in a Murine Model Against Intranasal Haemophilus influenzae Challenge},
journal = {Vaccines},
year = {2026},
volume = {14},
number = {4},
pages = {357},
doi = {10.3390/vaccines14040357}
}
EUVIMED